Trial Outcomes & Findings for Improving Neuropathy and Mobility in People With Early Diabetes (NCT NCT00780559)
NCT ID: NCT00780559
Last Updated: 2021-04-09
Results Overview
Measures distance covered by participant when walking at a brisk pace without running for six minutes in feet.
COMPLETED
NA
72 participants
Six Months
2021-04-09
Participant Flow
Participants were excluded from the study prior to assignment for groups (n=12) due to failure of screening (e.g. not meeting inclusion/exclusion criteria, n=10) or declined to participate (n=2.)
Participant milestones
| Measure |
Tailored Diet and Physical Activity
Tailored Diet and Physical Activity: Subjects will receive an individually tailored diet and physical activity enhancement program
|
Standard of Care
Standard of Care: Subjects will be told to reduce their baseline weight by 7% and exercise for 150 minutes/week. There is no tailored, directed program.
|
|---|---|---|
|
Overall Study
STARTED
|
32
|
40
|
|
Overall Study
COMPLETED
|
29
|
33
|
|
Overall Study
NOT COMPLETED
|
3
|
7
|
Reasons for withdrawal
| Measure |
Tailored Diet and Physical Activity
Tailored Diet and Physical Activity: Subjects will receive an individually tailored diet and physical activity enhancement program
|
Standard of Care
Standard of Care: Subjects will be told to reduce their baseline weight by 7% and exercise for 150 minutes/week. There is no tailored, directed program.
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
2
|
7
|
|
Overall Study
Death
|
1
|
0
|
Baseline Characteristics
Improving Neuropathy and Mobility in People With Early Diabetes
Baseline characteristics by cohort
| Measure |
Tailored Diet and Physical Activity
n=32 Participants
Subjects will receive an individually tailored diet and physical activity enhancement program
|
Standard of Care
n=40 Participants
Subjects will be told to reduce their baseline weight by 7% and exercise for 150 minutes/week. There is no tailored, directed program.
|
Total
n=72 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
18 Participants
n=99 Participants
|
28 Participants
n=107 Participants
|
46 Participants
n=206 Participants
|
|
Age, Categorical
>=65 years
|
14 Participants
n=99 Participants
|
12 Participants
n=107 Participants
|
26 Participants
n=206 Participants
|
|
Age, Continuous
|
61.81 Years
STANDARD_DEVIATION 8.25 • n=99 Participants
|
61.03 Years
STANDARD_DEVIATION 7.83 • n=107 Participants
|
61.38 Years
STANDARD_DEVIATION 7.91 • n=206 Participants
|
|
Sex: Female, Male
Female
|
11 Participants
n=99 Participants
|
13 Participants
n=107 Participants
|
24 Participants
n=206 Participants
|
|
Sex: Female, Male
Male
|
21 Participants
n=99 Participants
|
27 Participants
n=107 Participants
|
48 Participants
n=206 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=99 Participants
|
1 Participants
n=107 Participants
|
1 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Black or African American
|
5 Participants
n=99 Participants
|
7 Participants
n=107 Participants
|
12 Participants
n=206 Participants
|
|
Race (NIH/OMB)
White
|
26 Participants
n=99 Participants
|
30 Participants
n=107 Participants
|
56 Participants
n=206 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=99 Participants
|
2 Participants
n=107 Participants
|
3 Participants
n=206 Participants
|
|
BMI (Body Mass Index), Categorical
BMI < 30 kg/m^2
|
13 Participants
n=99 Participants
|
19 Participants
n=107 Participants
|
32 Participants
n=206 Participants
|
|
BMI (Body Mass Index), Categorical
BMI 30 - 40 kg/m^2
|
12 Participants
n=99 Participants
|
19 Participants
n=107 Participants
|
31 Participants
n=206 Participants
|
|
BMI (Body Mass Index), Categorical
BMI > 40 kg/m^2
|
7 Participants
n=99 Participants
|
2 Participants
n=107 Participants
|
9 Participants
n=206 Participants
|
|
BMI (Body Mass Index), Continuous
|
33.21 kg/m^2
STANDARD_DEVIATION 7.65 • n=99 Participants
|
30.83 kg/m^2
STANDARD_DEVIATION 7.06 • n=107 Participants
|
31.89 kg/m^2
STANDARD_DEVIATION 7.37 • n=206 Participants
|
PRIMARY outcome
Timeframe: Six MonthsMeasures distance covered by participant when walking at a brisk pace without running for six minutes in feet.
Outcome measures
| Measure |
Tailored Diet and Physical Activity
n=32 Participants
Subjects will receive an individually tailored diet and physical activity enhancement program
|
Standard of Care
n=40 Participants
Subjects will be told to reduce their baseline weight by 7% and exercise for 150 minutes/week. There is no tailored, directed program.
|
|---|---|---|
|
Six Minute Walk (6MW) Test
|
156.644156 feet
Standard Error 35.364227
|
61.257846 feet
Standard Error 35.840649
|
PRIMARY outcome
Timeframe: Baseline and 12 MonthsOutcome measures
| Measure |
Tailored Diet and Physical Activity
n=32 Participants
Subjects will receive an individually tailored diet and physical activity enhancement program
|
Standard of Care
n=40 Participants
Subjects will be told to reduce their baseline weight by 7% and exercise for 150 minutes/week. There is no tailored, directed program.
|
|---|---|---|
|
Change in 6-Minute-Walk Test Measured in Feet Between Baseline and 12 Months
|
188.415845 feet
Standard Error 34.346235
|
100.559319 feet
Standard Error 36.399507
|
SECONDARY outcome
Timeframe: 12 MonthsMeasure of the number of skin fibers/mm in the lower extremity (distal leg) at 12 months
Outcome measures
| Measure |
Tailored Diet and Physical Activity
n=32 Participants
Subjects will receive an individually tailored diet and physical activity enhancement program
|
Standard of Care
n=40 Participants
Subjects will be told to reduce their baseline weight by 7% and exercise for 150 minutes/week. There is no tailored, directed program.
|
|---|---|---|
|
Intraepidermal Nerve Fiber Density (Distal Leg)
|
1.28627099 fibers/mm
Standard Error 0.81830712
|
-0.38943425 fibers/mm
Standard Error 0.84781677
|
SECONDARY outcome
Timeframe: 12 MonthsMeasure of the number of skin fibers/mm in the lower extremity (proximal thigh) at 12 months
Outcome measures
| Measure |
Tailored Diet and Physical Activity
n=32 Participants
Subjects will receive an individually tailored diet and physical activity enhancement program
|
Standard of Care
n=40 Participants
Subjects will be told to reduce their baseline weight by 7% and exercise for 150 minutes/week. There is no tailored, directed program.
|
|---|---|---|
|
Intraepidermal Nerve Fiber Density (IENFD) at the Proximal Thigh
|
1.53825016 fibers/mm
Standard Error 0.83395303
|
-0.54419990 fibers/mm
Standard Error 0.87926529
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline and 12 MonthsPhysical Activity measured by CHAMPS provides an estimated caloric expenditure of subject based on weight and weekly physical activity, as assessed by the questionnaire. Change in physical activity is determined by the difference in daily caloric expenditure at baseline and 12 months.
Outcome measures
| Measure |
Tailored Diet and Physical Activity
n=32 Participants
Subjects will receive an individually tailored diet and physical activity enhancement program
|
Standard of Care
n=40 Participants
Subjects will be told to reduce their baseline weight by 7% and exercise for 150 minutes/week. There is no tailored, directed program.
|
|---|---|---|
|
Change in Physical Activity (PA) at 12 Months as Measured by the CHAMPS (Community Health Activities Model Program for Seniors) Activity Scale
|
-735.249060 kcal/day
Standard Error 886.986000
|
296.998122 kcal/day
Standard Error 937.935990
|
Adverse Events
Tailored Diet and Physical Activity
Standard of Care
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Tailored Diet and Physical Activity
n=32 participants at risk
Subjects will receive an individually tailored diet and physical activity enhancement program
|
Standard of Care
n=40 participants at risk
Subjects will be told to reduce their baseline weight by 7% and exercise for 150 minutes/week. There is no tailored, directed program.
|
|---|---|---|
|
Product Issues
Skin Irritation
|
3.1%
1/32 • Number of events 1 • Adverse event data for each participant was collected over one year per study patient, or the duration of the study for each participant.
The definition of adverse events and/or serious adverse events does not differ from that which is listed here on clinicaltrials.gov. Adverse Events were collected from patient reports and phone call follow-ups.
|
0.00%
0/40 • Adverse event data for each participant was collected over one year per study patient, or the duration of the study for each participant.
The definition of adverse events and/or serious adverse events does not differ from that which is listed here on clinicaltrials.gov. Adverse Events were collected from patient reports and phone call follow-ups.
|
Additional Information
Clinical Research Coordinator
University of Maryland School of Medicine
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place